IP Library › Granted Patent US 10,119,120
Granted Patent B2
US 10,119,120 · App. 13/390,225 · Granted Nov 6, 2018

Method for inducing differentiation of pluripotent stem cells into neural precursor cells

Inventors: Jun Takahashi (Kyoto, JP); Asuka Morizane (Kyoto, JP)
Assignee: Kyoto University
C12N5/0618C12N2501/155C12N2506/02C12N2506/45
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,119,120
App. No.
13/390,225
Granted
Nov 6, 2018
Kind
B2
Abstract

The present invention provides a method for inducing differentiation of pluripotent stem cells into neural precursor cells, comprising culturing the pluripotent stem cells in the presence of a small molecule BMP inhibitor, and induced neural precursor cells prepared by this method.

Claims (12)

1. A method for inducing differentiation of a pluripotent cell into a neural precursor cell, the method comprising:

treating the pluripotent stem cell with a p160-Rho-associated coiled-coil kinase (ROCK) inhibitor; and

culturing the treated pluripotent stem cell for inducing the differentiation into the neural precursor cell in a culture medium comprising substances consisting of 4-(6-(4-(piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline (LDN-193189) and a TGFβ family inhibitor selected from the group consisting of 4-[4-(1,3-benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]benzamide (SB431542) and 3-(6-methylpyridin-2-yl)-1-phenylthiocarbamoyl-4-quinolin-4-ylpyrazole (A-83-01), wherein the concentration of LDN-193189 is 50 nM or higher.

2. The method of claim 1 , wherein the culture medium further comprises a feeder cell, which is a stromal cell.

3. The method of claim 2 , wherein the stromal cell is a mouse stromal cell.

4. The method of claim 1 , wherein the culture medium is serum free and prior to the culturing of the differentiation induction an embryoid body is formed from the pluripotent stem cell.

5. The method of claim 1 , wherein the culture is performed on a Matrigel coated dish without feeder cells.

6. The method of claim 1 , wherein the pluripotent stem cell is an embryonic stem cell or an induced pluripotent stem cell.

7. The method of claim 1 , wherein the TGFβ family inhibitor is 4-[4-(1,3-benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]benzamide (SB431542).

8. The method of claim 1 , wherein the TGFα family inhibitor is 3-(6-methylpyridin-2-yl)-1-phenylthiocarbamoyl-4-quinolin-4-ylpyrazole(A-83-01).

9. The method of claim 1 , wherein the pluripotent stem cell is an embryonic stem cell.

10. The method of claim 1 , wherein the pluripotent stem cell is an induced pluripotent stem cell.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2012
From: TAKAHASHI, JUN; MORIZANE, ASUKA
To: KYOTO UNIVERSITY
Reel/Frame 027701/0555 →
Continuity (3)
Provisional Application 61272055 · Aug 12, 2009
Provisional Application 61282970 · Apr 30, 2010
Related Publication 20120142093A1 · Jun 7, 2012
Cited By (1)
US 12,492,373